EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Origanum majorana Extracts: A Preliminary Comparative Study on Phytochemical Profiles and Bioactive Properties of Valuable Fraction and By-Product

Simone Bianchi iD, Rosaria Acquaviva, Claudia Di Giacomo iD, Laura Siracusa iD, Leeyah Issop-Merlen iD, Roberto Motterlini iD, Roberta Foresti iD, Donata Condorelli, Giuseppe Antonio Malfa iD

Plants · 23.07.2025 · 14 (15) · 2264

DOI: 10.3390/plants14152264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Plants, online erschienen am 23.07.2025. Verfasst von Simone Bianchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Origanum majorana L. (O. majorana) (Lamiaceae) is an aromatic Mediterranean plant widely used in food, cosmetics, and traditional medicine due to its aroma and rich content of bioactive compounds. While its leaves and flowers are commonly utilized, lignified stems are often discarded. This study compared hydroalcoholic extracts from the leaves and flowers (valuable fraction, VF) and stems (by-product, BP). Phytochemical analysis revealed qualitatively similar profiles, identifying 20 phenolic compounds, with Rosmarinic acid and Salvianolic acid B as the most and second most abundant, respectively. Antioxidant activity was evaluated in vitro using DPPH (IC50 [µg/mL]: VF 30.11 ± 3.46; BP 31.72 ± 1.46), H2O2 (IC50 [µg/mL]: VF 103.09 ± 4.97; BP 119.55 ± 10.58), and O2•− (IC50 [µg/mL]: VF 0.71 ± 0.062; BP 0.79 ± 0.070). Both extracts (20 µg/mL) fully restored oxidative balance in hemin-stressed AC16 cardiomyocytes, without altering the expression of catalase, heme-oxygenase 1, superoxide dismutase 2, or ferritin. Anti-inflammatory activity in LPS-stimulated RAW 264.7 macrophages showed that VF (IC50 400 µg/mL) reduced •NO release to control levels, while BP achieved a ~60% reduction. Cytotoxicity was assessed on cancer cell lines: CaCo-2 (IC50 [µg/mL]: VF 154.1 ± 6.22; BP 305.2 ± 15.94), MCF-7 (IC50 [µg/mL]: VF 624.6 ± 10.27; BP 917.9 ± 9.87), and A549 (IC50 [µg/mL]: VF 720.8 ± 13.66; BP 920.2 ± 16.79), with no cytotoxicity on normal fibroblasts HFF-1 (IC50 > 1000 µg/mL for both extracts). Finally, both extracts slightly inhibited only CYP1A2 (IC50 [µg/mL]: VF 497.45 ± 9.64; BP 719.72 ± 11.37) and CYP2D6 (IC50 [µg/mL]: VF 637.15 ± 14.78, BP 588.70 ± 11.01). These results support the potential reuse of O. majorana stems as a sustainable source of bioactive compounds for nutraceutical and health-related applications.

Schlagwörter

Stichwörter der Autor:innen

Rosmarinic acidcancercytochrome P450 isoformsinflammationoxidative stresspolyphenolssustainability

Autor:innen und Institutionen

  • Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
  • Research Centre on Nutraceuticals and Health Products (CERNUT), University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
  • Italian National Research Council ICB-CNR, Institute of Biomolecular Chemistry, Via Paolo Gaifami 18, 95126 Catania, Italy.
  • Institut National de la Santé et de la Recherche Médicale (INSERM), Mondor Institute for Biomedical Research (IMRB), Faculty of Health, University Paris-Est Créteil, F-94010 Créteil, France.

ORCID-Profile: Simone Bianchi, Claudia Di Giacomo, Laura Siracusa, Leeyah Issop-Merlen, Roberto Motterlini, Roberta Foresti, Giuseppe Antonio Malfa

Förderung

  • Fondation pour la Recherche Médicale

Zitieren

APA

Bianchi, S., Acquaviva, R., Di Giacomo, C., Siracusa, L., Issop-Merlen, L., Motterlini, R., Foresti, R., Condorelli, D., & Malfa, G. A. (2025). Origanum majorana Extracts: A Preliminary Comparative Study on Phytochemical Profiles and Bioactive Properties of Valuable Fraction and By-Product. Plants, 14(15), 2264. https://doi.org/10.3390/plants14152264

Vancouver

Bianchi S, Acquaviva R, Di Giacomo C, Siracusa L, Issop-Merlen L, Motterlini R, et al. Origanum majorana Extracts: A Preliminary Comparative Study on Phytochemical Profiles and Bioactive Properties of Valuable Fraction and By-Product. Plants. 2025;14(15):2264. doi:10.3390/plants14152264

BibTeX
@article{Bianchi2025,
  author = {Bianchi, Simone and Acquaviva, Rosaria and Di Giacomo, Claudia and Siracusa, Laura and Issop-Merlen, Leeyah and Motterlini, Roberto and Foresti, Roberta and Condorelli, Donata and Malfa, Giuseppe Antonio},
  title = {Origanum majorana Extracts: A Preliminary Comparative Study on Phytochemical Profiles and Bioactive Properties of Valuable Fraction and By-Product},
  journal = {Plants},
  year = {2025},
  volume = {14},
  number = {15},
  pages = {2264},
  doi = {10.3390/plants14152264}
}
Kostenlos starten →